Danish Biotech Firm Alcolase Targets East Asia with Enzyme-Based Solution for Alcohol Intolerance
Korea South, 26th May 2025, – Seoul, South Korea — For nearly 30% of East Asians who suffer from alcohol intolerance — often referred to as “Asian flush” — drinking can trigger symptoms ranging from facial redness and nausea to rapid heartbeat and vomiting. Danish biotech startup Alcolase ApS is developing groundbreaking solution: a patented enzyme supplement that can break down alcohol directly in the stomach, potentially transforming how millions experience alcohol. Founded in Denmark, Alcolase is developing the world’s
Read more